Trial
NCT03109847
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
—
Condition
Thyroid
Intervention
Metformin Hydrochloride
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-11